Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02776111 · ClinicalTrials.gov registry record
Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients
A clinical trial, sponsored by University of Florida.
- Terminated
- Registry status
- 7
- Enrollment target
NCT02776111 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 7 participants.
The verdict
NCT02776111 was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and application of microarrays expands, researchers are developing more intelligent ways to provide individualized care for patients. The plan of this research study is to apply the use of genomics as a tool for transplant in several capacities. This research study is designed to develop methods of isolating relevant cell types via microarray plates, then extracting mRNA samples of those cell types and capturing their genetic profile. This will be done with the blood of up to ten healthy donors. Once this ability has been demonstrated, the next step will be to use these testing in several capacities in transplant patients. The research study plan involves following the genetic profile of 26 kidney transplant patients. One group will be followed prospectively starting at baseline, and then at various set time points. A second group will be sampled with the occurrence of clinical events. These events include viral, bacterial, and fungal infection, WBC \< 2.5 or biopsy proven rejection episodes or normal graft function. Thus, the intention of the study is to demonstrate how immunosuppression alters the expression of this genetic expression of these T cells. In doing so, the study will provide a better understanding of the specific and true immunosuppressed state for any given patient.
Interventions
- OTHER Blood Sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-07 |
| Est. Completion | 2019-06-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02776111
The ClinicalTrials.gov registry entry for NCT02776111 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Sample is the first listed.
NCT02776111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02776111 about?
NCT02776111 is a clinical study titled "Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients". The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and application of microarrays expands, researchers are developing more intelligent ways to provide individualized ca...
What is the current status of trial NCT02776111?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2016-07. Estimated completion is 2019-06-26.
What interventions are being tested in trial NCT02776111?
The interventions under investigation include: Blood Sample (OTHER).
Who is sponsoring clinical trial NCT02776111?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.